<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Wed, 08 Apr 2026 23:05:06 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/@aiyren/rss" rel="self" type="application/rss+xml"/><item><title><![CDATA[ETF 투자 지표 (2018.5.17)]]></title><description><![CDATA[오늘의 ETF (2018.5.17) KODEX 미국S&P바이오(합성) (185680) 수익률 : 당일(+1.81%), 1/3/6/12개월(+4.5%/+4.8%/+14.6%/+28.1%) 투자지표 : 변동성(27위), 모멘텀(8위), 종합(8위) 기초지수 : S&P Biotechnology Select Industry Index *본 포스팅은 투자자]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-5-17</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-5-17</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Thu, 17 May 2018 12:27:30 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdD7oStHarQMouhZDMtDJxu6KtUX71xVjV8L3GrB1RJoK4rWjk7jyoz4zCBE2zUy4Udc1dwCRzNnvq4gUBL5rC1e7wRvmS9nX8ctKWLAURjMhuw3H5ajwWWJ?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.5.16)]]></title><description><![CDATA[오늘의 ETF (2018.5.16) TIGER 200 건설 (139220) 수익률 : 당일(-4.3%), 1/3/6/12개월(+18.6%/+29.0%/+32.1%/+20.9%) 투자지표 : 변동성(80위), 모멘텀(1위), 종합(16위) 주요종목 : 현대건설(24.0%), 삼성엔지니어링(12.6%), GS건설(10.6%) 기초지수 : 코스피 200 건설 *본]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-5-16</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-5-16</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Wed, 16 May 2018 12:11:03 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdCjbrjk9aCadjria4rAd7JmGNPvBGbR3oDowbS8XppyUCaKMpuySgZMaHCLrWHeGvbtmPwzaPfRxkZjsSXFSzz8xfZ2ataZ7iXENGoKeVDE1RoHhk37J2Q6?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.5.15)]]></title><description><![CDATA[오늘의 ETF (2018.5.15) TIGER 가격조정 (217790) 수익률 : 당일(-0.8%), 1/3/6/12개월(+3.9%/+5.7%/+8.4%/+20.8%) 투자지표 : 변동성(2위), 모멘텀(10위), 종합(1위) 주요종목 : 아세아시멘트(4.4%), 한일시멘트(4.1%), LS(3.7%) 기초지수 : FnGuide Contrarian Index]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-5-15</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-5-15</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Tue, 15 May 2018 12:31:15 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdD7uzAfDA2xKnQYPdYCGMYc4WqrgmRkbGhD9RNAQnbfyNfJbnw5hpTFAKb3qDVnJaPm4ffg4NFrvHTQ9a4uWBJFYWuVLiyiKrFk22hKr3DthBfpCg6tqwbC?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.5.14)]]></title><description><![CDATA[오늘의 ETF (2018.5.14) TIGER 200 건설 (139220) 수익률 : 당일(+7.36%), 1/3/6/12개월(+24.1%/+30.8%/+33.6%/+23.5%) 투자지표 : 변동성(83위), 모멘텀(1위), 종합(13위) 주요종목 : 현대건설(22.4%), 삼성엔지니어링(12.6%), 대림산업(10.7%) 기초지수 : 코스피 200 건설 *본]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-5-14</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-5-14</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Mon, 14 May 2018 13:01:00 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdCiAnx3Sa2WuE2FTPvheBy8WNh6c1hEwNNhvhdT4gMfBastDcYEvohE1ASfg1aZMeFeYgy7pAPzVjKoKAwZJe3nPYsPHWz1szwLpdSyqQkWwTuB1MtyBW78?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.5.10)]]></title><description><![CDATA[오늘의 ETF (2018.5.10) KODEX 턴어라운드투자 (247800) 수익률 : 당일(+2.7%), 1/3/6/12개월(+11.2%/+4.8%/+12.0%/+15.7%) 투자지표 : 변동성(66위), 모멘텀(4위), 종합(8위) 주요종목 : 두산엔진(5.1%), 현대건설(4.9%), GS건설(4.3%) 기초지수 : FnGuide 턴어라운드투자형 지수]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-5-10</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-5-10</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Thu, 10 May 2018 12:58:15 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdCq7c93BoqVzTaXq2RRKbzyEzGLChLfq9HJLztVRrLC5cSKQjW543h2xbnyGtZYfPZzF42B1meCJFHYP7F48rYwwwqtwuGLbpe4rv3tNXmx4Fqdb2MsdX42?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.5.9)]]></title><description><![CDATA[오늘의 ETF (2018.5.9) TIGER 헬스케어 (143860) 수익률 : 당일(+6.62%), 1/3/6/12개월(-12.9%/-6.5%/+23.9%/+61.8%) 투자지표 : 변동성(44위), 모멘텀(127위), 종합(105위) 주요종목 : 셀트리온(21.3%), 셀트리온헬스케어(8.2%), 삼성바이오로직스(7.3%) 기초지수 : KRX 헬스케어 지수]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-5-9</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-5-9</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Wed, 09 May 2018 13:07:00 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdCoaprJQM799HLA4w771XQHUxU7jgmhnTtGcK5YPfFGmuWj7Y4Fyrf4hvJeFEwXJg9tkYV9xK8jAWacZ1VJ7pJuahPTxjmRhBZY2e7RvJbvp6k1eZH8XkHU?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.5.8)]]></title><description><![CDATA[오늘의 ETF (2018.5.8) TIGER 헬스케어 (143860) 수익률 : 당일(-4.17%), 1/3/6/12개월(-18.2%/-17.2%/+18.3%/+51.2%) 투자지표 : 변동성(40위), 모멘텀(151위), 종합(123위) 주요종목 : 셀트리온(21.7%), 셀트리온헬스케어(8.4%), 삼성바이오로직스(6.8%) 기초지수 : KRX 헬스케어]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-5-8</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-5-8</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Tue, 08 May 2018 12:06:36 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdDC9Wy1BaGD24kfza3FHHR1H6sQQupXZq3rwW4eESHrTtCVcEAn6BZYtH232xtcqZi7QZLoLiQDPV5N5wxU7HePXBWUWPXDsyQAgBd3v14oa5KPBh1stFQa?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.5.4)]]></title><description><![CDATA[오늘의 ETF (2018.5.4) TIGER 200 건설 (139220) 수익률 : 당일(+3.44%), 1/3/6/12개월(+23.5%/+12.2%/+24.4%/+19.7%) 투자지표 : 변동성(106위), 모멘텀(1위), 종합(11위) 주요종목 : 현대건설(21.7%), 삼성엔지니어링(12.5%), 대림산업(11.2%) 기초지수 : 코스피 200 건설지수]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-5-4</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-5-4</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Fri, 04 May 2018 12:22:27 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdCktnGcfhyfaiP8TxsFaoMDhSgZa2dT7MfgNpyh936oRQkrP1f4qiJ9cvmBLe4k3ZyBgCG4Hf7e95QZnM7JR4v754QqrwNZ8FJ8PET5RYFLuWr8X4vJYeia?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.4.30)]]></title><description><![CDATA[오늘의 ETF (2018.4.30) TIGER 200 건설 (139220) 수익률 : 당일(+9.2%), 1/3/6/12개월(+20.0%/+10.3%/+25.1%/+18.7%) 투자지표 : 변동성(122위), 모멘텀(1위), 종합(19위) 주요종목 : 현대건설(19.1%), 삼성엔지니어링(13.2%), 대림산업(11.6%) 기초지수 : 코스피 200 건설지수]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-4-30</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-4-30</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Mon, 30 Apr 2018 11:56:51 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdDDKmfAz3P8mSpofjnrhRfti29gCgRghbQnwBBS2xcvnicMbuDZPL8iwcpexFh5nZGixXCG6D82dxRo4wrAdU6tfuFh23xbJTiLEztcDjykVJzATVC8f9mG?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.4.27)]]></title><description><![CDATA[오늘의 ETF (2018.4.27) TIGER 헬스케어 (143860) 수익률 : 당일(+2.65%), 1/3/6/12개월(-5.0%/-9.1%/+39.0%/+86.3%) 투자지표 : 변동성(23위), 모멘텀(138위), 종합(102위) 주요종목 : 셀트리온(20.4%), 삼성바이오로직스(8.7%), 셀트리온헬스케어(8.3%) 기초지수 : KRX 헬스케어 지수]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-4-27</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-4-27</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Fri, 27 Apr 2018 12:18:39 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdCnTgCoSEX2FVTwkSX4VoP1RCHw1wZZ86tnAkW59LcEce4XqsfiuVotpNm5eyHQaYnJkDSXWqCcWFE49CWvSBxvtjymZcP7fiZ5DuNhksguc9UZHorfvJnA?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.4.26)]]></title><description><![CDATA[오늘의 ETF (2018.4.26) KODEX 바이오 (244580) 수익률 : 당일(+3.12%), 1/3/6/12개월(+8.0%/+0.0%/+52.2%/+76.6%) 투자지표 : 변동성(9위), 모멘텀(7위), 종합(1위) 주요종목 : 안트로젠(3.1%), 프로스테믹스(2.9%), 오스코텍(2.8%) 기초지수 : FnGuide 바이오 지수 *본 포스팅은]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-4-26</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-4-26</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Thu, 26 Apr 2018 11:49:36 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdCrVt83BgbyKSTEoWuNK2R2EWaBisvVRqtTG7q9uRa2sRwMFrLk5PDxCy1CzqpmLyZrR7tmFEdYbu16g1uK2iVK5eUTMBDgeMJfvTAtARqSqdsGLWi7WWza?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.4.24)]]></title><description><![CDATA[오늘의 ETF (2018.4.24) TIGER 여행레저 (228800) 수익률 : 당일(+1.51%), 1/3/6/12개월(+11.8%/+8.6%/+24.2%/+34.5%) 투자지표 : 변동성(80위), 모멘텀(1위), 종합(7위) 주요종목 : 강원랜드(10.4%), 한진칼(10.3%), 아시아나항공(9.8%) 기초지수 : WISE 여행레저 지수 *본 포스팅은]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-4-24</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-4-24</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Tue, 24 Apr 2018 12:39:33 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdD6XVckKEBnz8msejKcNb4Snjs4yYNxcJ38UQvqqsDJfnhFhPyvxFC3GVZk2zMdsc2SA3CwncWus4GyVPrQXQPQ3JipikbMxfkxW7toEafcRTaAEWxDPbwL?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.4.23)]]></title><description><![CDATA[오늘의 ETF (2018.4.23) KODEX 헬스케어 (266420) 수익률 : 당일(-4.8%), 1/3/6/12개월(-5.2%/-9.1%/+35.2%/+74.3%) 투자지표 : 변동성(77위), 모멘텀(151위), 종합(130위) 주요종목 : 셀트리온(21.0%), 삼성바이오로직스(8.7%), 셀트리온헬스케어(8.0%) 기초지수 : KRX 헬스케어 지수]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-4-23</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-4-23</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Mon, 23 Apr 2018 11:18:48 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdCvXjJojNMSspfAq8v79YJWkLxgH8i9rPC9mEfXJf5RPYiYL2GbB2zpB7XLB7BYcqQNCwJw6kdz58SbZj76m4mX2PUSpVRmimKN5ZYAQy6agj1KgFe7kqeE?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.4.20)]]></title><description><![CDATA[오늘의 ETF (2018.4.20) KODEX 경기소비재 (266390) 수익률 : 당일(+1.7%), 1/3/6/12개월(+5.6%/+1.6%/+15.7%/+21.1%) 투자지표 : 변동성(94위), 모멘텀(11위), 종합(12위) 주요종목 : LG전자(23.7%), 코웨이(9.3%), 강원랜드(7.2%) 기초지수 : KRX 경기소비재 지수 *본 포스팅은]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-4-20</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-4-20</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Fri, 20 Apr 2018 11:32:12 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdD7uhM93BUKZFD9yW3AD4u7F4RSAADwNZo3zinswF7sqwHtHvDHZDGz3Dd9Wq6xPAhbhrbmi47L7DKj9Q4BHVQ15HvbrjMJbKbiaonmncUogAAsQP2nTPbU?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.4.19)]]></title><description><![CDATA[오늘의 ETF (2018.4.19) TIGER 200 건설 (139220) 수익률 : 당일(+5.0%), 1/3/6/12개월(+13.2%/+9.8%/+15.8%/+10.6%) 투자지표 : 변동성(159위), 모멘텀(3위), 종합(33위) 주요종목 : 현대건설(17.4%), 삼성엔지니어링(14.4%), 현대산업(13.6%) 기초지수 : 코스피 200 건설 지수]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-4-19</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-4-19</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Thu, 19 Apr 2018 13:40:51 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdCgreTzMgT7p7nFsFNyRKf9aRdm2fwTW66gKgseiQMkjhyKStRUwShXq4SjuexSwc6iWpgKyL9xUPJLfn6Guc4ZfA2ud6k28ouNR7YnhvzCeV6DRgTjLzpe?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.4.18)]]></title><description><![CDATA[오늘의 ETF (2018.4.18) TIGER 여행레저 (228800) 수익률 : 당일(+1.5%), 1/3/6/12개월(+7.8%/+9.5%/+32.6%/+33.9%) 투자지표 : 변동성(81위), 모멘텀(2위), 종합(9위) 주요종목 : 아시아나항공(10.2%), 파라다이스(10.2%), 강원랜드(9.9%) 기초지수 : Wise 여행레저 지수 *본 포스팅은]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-4-18</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-4-18</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Wed, 18 Apr 2018 12:59:21 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdCkpzVwPM78a3qxGYAhH5znbiPNRK1h1f2F56bq6JWeRfn8K4h3oZRAopZdKH5K94eM1X7sDJeXhKZz7E24eHmv3QVdK5HRPh2XxzrcPW8X3kdsHWscnT5Y?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.4.17)]]></title><description><![CDATA[오늘의 ETF (2018.4.17) TIGER 미디어컨텐츠 (228810) 수익률 : 당일(+1.1%), 1/3/6/12개월(+2.0%/+9.2%/+35.1%/+37.0%) 투자지표 : 변동성(42위), 모멘텀(5위), 종합(10위) 주요종목 : 스튜디오드래곤(10.4%), CJ E&M(10.4%), JYP Ent.(10.3%) 기초지수 : Wise]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-4-17</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-4-17</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Tue, 17 Apr 2018 12:50:03 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdDCCgSo26dhBocbYzEB1attLCKGEYJspF1DKK64RWQeK4MRgNUE1B5nM1N8XYNAjdTeKoGo1AQRBCYyg1qwBiu43zM3VCQNxbngoahhNXQ7EB1947FGuUDL?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.4.16)]]></title><description><![CDATA[오늘의 ETF (2018.4.16) KODEX 모멘텀Plus (244620) 수익률 : 당일(+0.6%), 1/3/6/12개월(+3.3%/+6.7%/+23.8%/+37.4%) 투자지표 : 변동성(2위), 모멘텀(3위), 종합(1위) 주요종목 : 고영(4.3%), 미래컴퍼니(4.3%), 인바디(4.1%) *기초지수 : FnGuide 모멘텀 Plus 지수 *본]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-4-16</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-4-16</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Mon, 16 Apr 2018 13:49:00 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdConARabWTdd3KqCdnzdLqMdRiQT93TV98MA5Y3Tjad95aBC4VkREH3xcCfHsdrUf1bhVMW7u3TKhWz8BthLm2M3VudanrB1gGWKekBtY1ZsabYGC5ZsBLa?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.4.13)]]></title><description><![CDATA[오늘의 ETF (2018.4.13) KODEX 모멘텀Plus (244620) 수익률 : 당일(+1.4%), 1/3/6/12개월(+2.9%/+8.2%/+24.5%/+37.5%) 투자지표 : 변동성(3위), 모멘텀(4위), 종합(2위) 주요종목 : 고영(4.3%), 인바디(4.2%), 미래컴퍼니(4.1%) *기초지수 : FnGuide 모멘텀 Plus 지수 *본]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-4-13</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-4-13</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Fri, 13 Apr 2018 11:40:24 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdDBpdzgW7oDn864UQSGK1AWJRCYTneHh2av4ECMijX4iLz7J3gBfDT81sroLV2nyS2ZLA922PGTb2U8jbwUB6ze8GbJM913z4GBhT2YHiDaBrEMRQpZFmNe?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[ETF 투자 지표 (2018.4.11)]]></title><description><![CDATA[오늘의 ETF (2018.4.11) KODEX 바이오 (244580) 수익률 : 당일(+2.7%), 1/3/6/12개월(+14.3%/+21.5%/+76.4%/+94.3%) 투자지표 : 변동성(38위), 모멘텀(1위), 종합(6위) 주요종목 : 안트로젠(4.0%), 프로스테믹스(3.2%), 오스코텍(3.0%) *기초지수 : FnGuide 바이오 지수 *본 포스팅은]]></description><link>http://direct.ecency.com/kr/@aiyren/etf-2018-4-11</link><guid isPermaLink="true">http://direct.ecency.com/kr/@aiyren/etf-2018-4-11</guid><category><![CDATA[kr]]></category><dc:creator><![CDATA[aiyren]]></dc:creator><pubDate>Wed, 11 Apr 2018 12:00:18 GMT</pubDate><enclosure url="https://images.ecency.com/p/W5LtFUPm6g774G2LPx8CTVHrbGQ778Sw45DBMcdCeCjAoZjKQwR3ZWELHo7W9x8rSMBE5Fw2uTY8jfHT3gFEsp3oGvkqoWQ5fD3XLkDnY9cMAsuhWnghWHFcJjExecP2XToDW6szqUjuzqq2oSjTH5Gz4kvMc?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>